![David Maggs](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Maggs
Vorstandsvorsitzender bei
Abvance Therapeutics, Inc.
Profil
David Maggs is the founder of Abvance Therapeutics, Inc. since 2016, holding the title of Chief Executive Officer.
Former positions include Director-Medical Research, Diabetes & Metabolism at Parke, Davis & Co. LLC from 1999, Vice President-Medical Affairs at Amylin Pharmaceuticals, Inc., and Chief Medical Officer at MORPHIC MEDICAL INC from 2013 to 2015.
Education includes a doctorate from the University of London.
Aktive Positionen von David Maggs
| Unternehmen | Position | Beginn |
|---|---|---|
Abvance Therapeutics, Inc.
 Abvance Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company developing insulin | Vorstandsvorsitzender | 01.01.2016 |
Ehemalige bekannte Positionen von David Maggs
| Unternehmen | Position | Ende |
|---|---|---|
| GI DYNAMICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 18.06.2015 |
Parke, Davis & Co. LLC
 Parke, Davis & Co. LLC Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Corporate Officer/Principal | 01.01.1999 |
Amylin Pharmaceuticals, Inc.
 Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes medicines for diabetes, obesity and cardiovascular diseases | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von David Maggs
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
11
Beziehungen ersten Grades
5
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes medicines for diabetes, obesity and cardiovascular diseases | Health Technology |
MORPHIC MEDICAL INC
 MORPHIC MEDICAL INC Medical SpecialtiesHealth Technology Designs, develops, and markets medical devices for the treatment of diabetes and obesity, and their complexities | Health Technology |
University of London
 University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Parke, Davis & Co. LLC
Parke, Davis & Co. LLC Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Health Technology |
Abvance Therapeutics, Inc.
Abvance Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company developing insulin | Health Technology |
